Be at the forefront of the insights from 60+ leading experts as they share their learnings on:
Commercialization challenges, the payers perspective and the investors' criteria for business in the current and future NASH market
The non-invasive diagnostics landscape and regulatory considerations on biomarker adoption for clinical trials
Computational methods and artificial intelligence to increase the efficiency of drug development
Scientific rationale of combinational therapeutics as the necessary treatment strategy for NASH to inform pairing decisions
Identification and recruitment of “high risk” patients needed to optimize clinical success and demonstrate sufficient efficacy
Time: 8:00 am to 5:00 pm
Gold Pass: Full Access (Conference Days + Seminar Day and 2 Workshops) : USD 4797.0,
Silver Pass: Conference + 1 Seminar : USD 4098.0,
Silver Pass: Conference + 2 Workshops:: USD 4098.0,
Bronze Pass: Conference Only: USD 2999.0,
Bronze Pass: Seminar Day Only: USD 1399.0,
Bronze Pass: 2 Workshops Only: USD 1399.0
Arrange meetings with companies at
3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
No attending suppliers listed at the moment. Be the first one to list your company here.
- The 4th Dubai International Conference on Infectious Diseases and Vaccination Infectious diseases are a major public health concern globally an...
- Changing GMP Behaviors About This Workshop People say behaviour change is hard. Well it...